Neonc Technologies, Inc.
Nasdaq NTHI · Calabasas, CA
Works in Dermatology · GI & liver · Hematology · Immunology · Infectious disease · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Neonc Technologies, Inc. is a clinical trial sponsor based in Calabasas, CA, listed as Nasdaq NTHI. It has 4 active clinical trials with 225 planned participants, across 10 therapeutic areas.
Trial track record · since 2021
Financials · Nasdaq NTHI
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
On the market · 0 products
No marketed products under this name.
Questions about Neonc Technologies, Inc
Neonc Technologies, Inc is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 225 planned participants, in Dermatology, GI & liver, Hematology, Immunology and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
Neonc Technologies, Inc is based in Calabasas, CA and is listed as Nasdaq NTHI. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Neonc Technologies, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-24.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-28.
Approve Suite is not affiliated with Neonc Technologies, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.